{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:29:52Z","timestamp":1791242992317,"version":"4.1.0"},"reference-count":35,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Intensive Care Med"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>COVID-19-related acute respiratory distress syndrome (ARDS) is linked to mortality, primarily due to a cytokine storm, oxidative stress imbalance, and pro-thrombotic state.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>We assessed the potential association between N-acetyl-cysteine (NAC) and clinical outcomes in critically ill subjects with COVID-19-related ARDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods<\/jats:title>\n                    <jats:p>We included subjects with confirmed COVID-19 who were admitted to our ICU between March 1, 2020, and January 31, 2021, due to ARDS and necessitating invasive mechanical ventilation (IMV). Subjects who received standard of care (SOC) were compared with subjects who additionally received NAC 600 mg bid orally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 243 subjects were included in this study. The results indicate significantly improved survival rates in the NAC plus SOC group, both in the unadjusted analysis and after adjusting for confounding factors such as ARDS severity (HR 0.48, 95% CI 0.32-0.70).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found that oral administration of NAC was associated with reduced mortality in critically ill patients with COVID-19 related ARDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08850666241281281","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T22:00:01Z","timestamp":1726264801000},"page":"284-293","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["N-acetyl-cysteine in Intensive Care Unit Patients with Acute Respiratory Distress Syndrome due to COVID-19: A Retrospective Cohort Study"],"prefix":"10.1177","volume":"40","author":[{"given":"Diego","family":"Gonz\u00e1lez-Guzm\u00e1n","sequence":"first","affiliation":[{"name":"Health science center, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"},{"name":"Department of Internal Medicine, Nuevo Hospital Civil de Guadalajara \u201cDr Juan I. Menchaca\u201d. Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Andrade-Castellanos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nuevo Hospital Civil de Guadalajara \u201cDr Juan I. Menchaca\u201d. Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-9913","authenticated-orcid":false,"given":"Marco A.","family":"Ponce-Gallegos","sequence":"additional","affiliation":[{"name":"Department of Clinical Cardiology, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mesina-Estarr\u00f3n","sequence":"additional","affiliation":[{"name":"Health science center, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7042-033X","authenticated-orcid":false,"given":"Jos\u00e9 G.","family":"Mora-Almanza","sequence":"additional","affiliation":[{"name":"Health science center, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo E.","family":"Ruelas-Moreno","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nuevo Hospital Civil de Guadalajara \u201cDr Juan I. Menchaca\u201d. Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rodr\u00edguez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of intensive care medicine, Nuevo Hospital Civil de Guadalajara \u201cDr Juan I. Menchaca\u201d, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Eguia-Ortega","sequence":"additional","affiliation":[{"name":"Department of intensive care medicine, Nuevo Hospital Civil de Guadalajara \u201cDr Juan I. Menchaca\u201d, Guadalajara, Jalisco, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Enrique","family":"Colunga-Lozano","sequence":"additional","affiliation":[{"name":"Health science center, Universidad de Guadalajara, Guadalajara, Jalisco, M\u00e9xico"},{"name":"Department of intensive care medicine, Nuevo Hospital Civil de Guadalajara \u201cDr Juan I. Menchaca\u201d, Guadalajara, Jalisco, M\u00e9xico"},{"name":"Department of Health Research Methods, Evidence and Impact. McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"COVID-19 cases \/ WHO COVID-19 dashboard [Internet]. [cited 2024 Jul 1]. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.11.009"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7218a4"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(23)00079-8"},{"key":"e_1_3_3_8_2","unstructured":"COVID-19 Treatment Guidelines [Internet]. [cited 2024 Jul 1]. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.07.008"},{"issue":"3","key":"e_1_3_3_10_2","first-page":"265","article-title":"N-Acetylcysteine: Multiple clinical applications","volume":"80","author":"Millea PJ","year":"2009","unstructured":"Millea PJ. N-Acetylcysteine: Multiple clinical applications. Am Fam Physician. 2009;80(3):265-269.","journal-title":"Am Fam Physician"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107916"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12171"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/00368504221074574"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.4103\/2045-9912.229599"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2021.1945675"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","unstructured":"Zhen JP Wen FQ Bai CX et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): A randomised double-blind placebo-controlled trial. Lancet Respir Med. 2014 Mar;2(3):187-194.","DOI":"10.1016\/S2213-2600(13)70286-8"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2020-0110"},{"issue":"23","key":"e_1_3_3_18_2","first-page":"2526","article-title":"Acute respiratory distress syndrome: The Berlin definition","volume":"307","author":"The ARDS Definition Task Force","year":"2012","unstructured":"The ARDS Definition Task Force. Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012;307(23):2526-2533. https:\/\/doi.org\/10.1001\/jama.2012.5669.","journal-title":"JAMA"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"e_1_3_3_21_2","unstructured":"KDIGO Clinical Practice Guideline for Acute Kidney Injury. [cited 2024 Jul 1]; Available from: http:\/\/www.kidney-international.org."},{"key":"e_1_3_3_22_2","unstructured":"CDC Ncezid DHQP. Ventilator-Associated Event (VAE). 2024."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2011-000681"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12839"},{"issue":"2","key":"e_1_3_3_25_2","article-title":"In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico city; causes of death, risk factors and the impact of hospital saturation","volume":"16","author":"Olivas-Mart\u00ednez A","year":"2021","unstructured":"Olivas-Mart\u00ednez A, C\u00e1rdenas-Fragoso JL, Jim\u00e9nez JV, et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico city; causes of death, risk factors and the impact of hospital saturation. PLoS One [Internet]. 2021;16(2):e0245772.","journal-title":"PLoS One [Internet]"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/1024907918794559"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1443"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28393"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-021-00296-2"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092235"},{"issue":"1","key":"e_1_3_3_31_2","first-page":"41","article-title":"N-acetylcysteine efficacy in patients hospitalized with COVID-19 pneumonia: A systematic review and meta-analysis","volume":"61","author":"Paraskevas T","year":"2023","unstructured":"Paraskevas T, Kantanis A, Karalis I, et al. N-acetylcysteine efficacy in patients hospitalized with COVID-19 pneumonia: A systematic review and meta-analysis. Rom J Intern Med. 2023;61(1):41-52.","journal-title":"Rom J Intern Med"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000869"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.11.009"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S273700"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001807"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.06.015"}],"container-title":["Journal of Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08850666241281281","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08850666241281281","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08850666241281281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:58:14Z","timestamp":1777503494000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08850666241281281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/08850666241281281"],"URL":"https:\/\/doi.org\/10.1177\/08850666241281281","relation":{},"ISSN":["0885-0666","1525-1489"],"issn-type":[{"value":"0885-0666","type":"print"},{"value":"1525-1489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]}}}